Dynamic Technology Lab Private LTD Eye Point Pharmaceuticals, Inc. Transaction History
Dynamic Technology Lab Private LTD
- $652 Million
- Q1 2025
A detailed history of Dynamic Technology Lab Private LTD transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 73,310 shares of EYPT stock, worth $947,165. This represents 0.06% of its overall portfolio holdings.
Number of Shares
73,310
Previous 32,178
127.83%
Holding current value
$947,165
Previous $239,000
66.11%
% of portfolio
0.06%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding EYPT
# of Institutions
164Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$108 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$87.9 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$87.9 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$57.1 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$55.6 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $440M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...